LPTI (Longport) Research & Development: $ Mil (TTM As of . 20)


What is Longport Research & Development?

Longport LPTI -99.00% Research & Development is $ Mil as of . 20.

Research & Development is the aggregate amount of research and development expenses during the year. Longport's Research & Development for the three months ended in . 20 was $0.00 Mil. Longport does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Longport  (OTCPK:LPTI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Longport Research & Development Related Terms

Longport Research & Development Historical Data

* Premium members only.

The historical data trend for Longport's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longport Research & Development Chart

Longport Annual Data
Trend
Research & Development

Longport Quarterly Data
Research & Development

Longport Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $ Mil mean?
Longport (LPTI) has a Research & Development of $ Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Longport and its competitors.
Is Longport's Research & Development too high?
Longport's current Research & Development is $ Mil.
How does Longport's Research & Development compare to PSID and GBSN?
Longport's Research & Development of $ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Longport and its competitors. Longport's current Research & Development is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longport stock overvalued right now?
Longport (LPTI) has a current Research & Development of $ Mil. The current Research & Development is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Longport (LPTI), the current Research & Development is $ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longport Business Description

Address 1620 Baltimore Pike, P.O. Box 768, Chadds Ford, PA, USA, 19317
Longport Inc is focused on developing, manufacturing, marketing, and selling high resolution ultrasound imaging systems. The company's applications serve the following market sectors: Wound assessment and prevention, Dermatology, Aesthetics, and Research, including validation of processes and products that impact the skin.